S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)
S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)
S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)
S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)

Eloxx Pharmaceuticals (ELOX) SEC Filings & 10K Form

$0.89
+0.03 (+3.49%)
(As of 03/1/2024 ET)

Recent Eloxx Pharmaceuticals SEC Filings

DateFilerForm TypeView
01/24/2024
8:44 PM
Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/09/2024
4:10 PM
Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/28/2023
3:11 PM
Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
3:58 PM
Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2023
4:26 PM
Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2023
3:05 PM
Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2023
12:26 PM
Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
Form 424B5
09/18/2023
7:05 AM
Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/15/2023
4:15 PM
Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/07/2023
9:14 AM
Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/29/2023
3:32 PM
Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2023
3:50 PM
Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2023
10:56 AM
Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/11/2023
3:05 PM
Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/13/2023
7:43 AM
Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/15/2023
8:15 AM
Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2023
7:32 PM
Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2023
7:40 AM
Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
Form 424B5
05/24/2023
7:07 AM
Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/03/2023
8:27 AM
Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ELOX) was last updated on 3/1/2024 by MarketBeat.com Staff